June 2020 – Canadian Association of Research Ethics Boards

Position Statements

CAREB-ACCER’s comments in response to the CCTCC REB Accreditation Working Group Consultation

Posted on June 21, 2020November 3, 2020 by admin

In May 2016, the REB Accreditation Working Group of the Canadian Clinical Trials Coordinating Centre (CCTCC) released its Draft Preliminary Recommendations (DRPs) for broad consultation. Attached is CAREB-ACCER’s response filed with CCTCC on June 20, 2016. File: CAREB-ACCER’s comments in response to the CCTCC REB Accreditation Working Group Consultation

Continue reading →

Newsroom

Joint Statement on Clinical Trial Oversight in Canada

Posted on June 15, 2020October 29, 2020 by admin

Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB-ACCER), issued a Joint Statement on Clinical Trials Oversight in Canada recognizing the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a medical […]

Continue reading →